Since the onset of the COVID-19 pandemic, at least 1 in 4 New York City (NYC) residents have been infected with SARS-CoV-2, the virus that causes COVID-19. While COVID-19 vaccines have reduced morbidity and mortality from COVID-19, older adults are still at higher...
Abstract: In 2021, long-acting cabotegravir (LA CAB) was approved by the United States Food and Drug Administration for an indication of pre-exposure prophylaxis in women. This is a first in what is hoped to be a robust pipeline of long-acting antiretroviral agents...
Routine data on vaccine uptake are not disaggregated by LGBTQ+ populations, despite higher risk of infection and severe disease. We found comparable vaccination uptake patterns among 1,032 LGBTQ+ New Yorkers to the general population. We identified critical...
The US recently suffered the fourth and most severe wave of the COVID-19 pandemic. This wave was driven by the SARS-CoV-2 Omicron, a highly transmissible variant that infected even vaccinated people. Vaccination coverage disparities have played an important role in...
Authors: Abigail R. Greenleaf, Monique Millington, Kiana Chan, Melissa Reyes, Shannon M. Farley, Andrea Low, David Hoos, Wafaa M. El‑Sadr To describe effects of the COVID-19 pandemic on older adults living in non-institutionalized settings in New York City (NYC) we...
